Asian Breast Diseases Association

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Contact Us


Advances in Breast Cancer Management – A Multidisciplinary Approach


Advances in Breast Cancer Management – A Multidisciplinary Approach aims at providing a timely update by international experts on luminal breast cancer detection, diagnosis and management. The speakers include Dr Peter Choi, Hong Kong Sanatorium, Hong Kong; Prof Seema Khan, Northwestern University, USA; Prof Sughra Raza, Harvard Medical School, USA and Dr Gary Tse, Prince of Wales Hospital, Hong Kong. The meeting will highlight the close interaction of all disciplines in holistic patient care.

Registration is closed.

Date: 22 Jan, 2018

Time: 18:30 – 20:00 (Registration: 17:30 – 18:30)

Venue: Function Room I, 3/F The Mira Hong Kong, 118 Nathan Road, Tsimshatsui, Kowloon, HK

Chairpersons:  Dr Helen Chau and Dr Gary Tse, Prince of Wales Hospital


Dr Peter Choi, Hong Kong Sanatorium, Hong Kong

Dr Peter Choi Ho Keung is currently Honorary Associate Professor of Clinical Oncology, Chinese University of Hong Kong. He is also a member of the Steering Committee of the Hong Kong Breast Cancer Registry. Dr Choi graduated from the University of Hong Kong and received radiotherapy and clinical oncology training in Hong Kong, the UK and the USA. Dr Choi has served in public hospitals for over 25 years. Prior to his private practice in 2005, he was Consultant in-charge of Department of Clinical Oncology at the Prince of Wales Hospital, Honorary Consultant of Bradbury Hospice and Clinical Co-ordinator of Clinical Oncology of New Territories East Cluster, Hong Kong.

Prof Seema Khan, Northwestern University, USA

Dr Seema Ahsan Khan is Professor of Surgery at the Feinberg School of Medicine at Northwestern University and is trained in Surgical Oncology. Her clinical practice at the Lynn Sage Comprehensive Breast Center includes the surgical therapy of women with breast cancer, and the evaluation and management of women at high risk for breast cancer. She also has an active research program in breast cancer risk assessment and prevention, and is PI of the Northwestern Cancer Prevention Consortium. This is funded by the Division of Cancer Prevention of the NCI, and conducts early-phase trials in cancer prevention at all organ sites.

Prof Sughra Raza, Harvard Medical School, USA

Prof Sughra Raza is an Associate Professor of Radiology in Harvard Medical School and Associate Director of Breast Imaging in Brigham and Women’s Hospital, Boston. She graduated from Albany Medical College, and build most of her career in Boston, firstly in Beth Israel Hospital and subsequently in BWH. She specializes in multimodalities diagnostic radiology of the breast.  Her research is focus on breast density and cancer risk, in-depth tissue analysis with imaging-pathology correlation, imaging genomics and personalized risk stratification. Her international teaching mainly covers the developing and limited resource regions of the world, including Armenia, Ukraine, Pakistan, Nigeria, Costa Rica, Mexico, Columbia, Haiti, Rwanda, and Nepal.

Dr Gary Tse, Prince of Wales Hospital, Hong Kong

Dr Gary Tse is a Senior Medical Officer and Honorary Clinical Associate Professor at Prince of Wales Hospital and the Chinese University of Hong Kong. Dr Tse’s main interest is in breast pathology. He was involved in the WHO breast tumor classification, TCGA breast pathology committee, and is Australasia Regional Editor for Histopathology, Section Head for Diagnostic Pathology, and serves on the editorial of peer reviewed journals including Acta Cytologica, Seminars in Diagnostic Pathology, EBioMedicine, Pathology, and Chinese Pathology Journal. He was an invited speaker to many regional and international conferences, and published more than 250 original journal articles.





Welcome Remarks

18:35 – 18:45

Luminal cancers classification update. (Gary Tse)

18:45 – 19:10

Advances in the imaging of early luminal breast cancers. (Sughra Raza)

19:10 – 19:35

Recent advances in the management of non-metastatic luminal breast cancers. (Seema Khan)

19:35 – 20:00

Optimization of treatment selection in HR positive advanced breast cancers.
(Peter Choi)

20:00 – 20:10

Q & A


Dinner (Full)

Sponsored by:


For detail, please download our program or email to us.

* CME 1.5 points from The College of Surgeons of Hong Kong
* CME 1 point from Hong Kong College of Pathologists
* CME from Hong Kong College of Radiologists application in progress.



Program: PDF Format

Enrollment Form: Sorry! Closed!

Best view on Firefox or Internet Explorer 7 or above | Last update: June 9, 2009